Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.22 USD | -1.70% | +11.04% | +662.91% |
Jun. 03 | Corbus Pharmaceuticals Reaches 2-Year High After Drug Results | DJ |
Jun. 03 | Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $80 From $60, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+662.91% | 502M | |
+18.49% | 125B | |
+14.10% | 109B | |
-2.76% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.10% | 16.64B | |
+0.20% | 13.45B | |
+22.88% | 11.32B |
- Stock Market
- Equities
- CRBP Stock
- News Corbus Pharmaceuticals Holdings, Inc.
- Sector Update: Health Care